IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
T-Cell Large Granular Lymphocyte Leukemia
Northwestern Universitymonoclonal_antibodyPhase 2Dormant
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the T-Cell Large Granular Lymphocyte Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
cc-5013 Fred Hutchinson Cancer Center | Phase 2 | B |
Irinotecan National Cancer Institute (NCI) | Phase 1 | CCC |
Inno-206 National Cancer Institute (NCI) | Phase 1 | CCC |
(+)-VINCRISTINE National Cancer Institute (NCI) | Phase 1 | CCC |
PREDNISONE TABLETS National Cancer Institute (NCI) | Phase 1 | CCC |
Dasatinib National Cancer Institute (NCI) | Phase 1 | CC |
Vorinostat National Cancer Institute (NCI) | Phase 1 | CC |
Alisertib National Cancer Institute (NCI) | Phase 1 | CC |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →